Preliminary Effectiveness of Process-Based Personalized Physiotherapy for (Sub)Acute Neck Pain

计划入组 11 人 · 首次发布于 2026 年 7 月 15 日

Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

计划入组 76 人 · 首次发布于 2019 年 3 月 12 日

Development of the Medicines Optimisation Assessment Tool

计划入组 1,552 人 · 首次发布于 2015 年 10 月 21 日

Pancreas (Oncodesign)(Enzepi)

CLK inhibitors (Oncodesign)

SIK2 inhibitors (Oncodesign)

Praxis Precision Medicines

United States

Praxis Precision Medicines Australia Pty Ltd.

Australia

Oncodesign SA

France

Oncodesign Precision Medicine Presents Positive Phase 1 Data for RIPK2 Inhibitor OPM-101 in Healthy Volunteers

Biognosys Partners with Michael J. Fox Foundation to Develop Critical LRRK2 Biomarker Assays for Parkinson's Disease

Oncodesign Precision Medicine and Navigo Proteins Terminate Radiotheranostics Collaboration